OcellO news

All Posts by: Karine Estur

First in human for MCLA-158!

MCLA-158 is a bispecific antibody created by Merus – one of a library of antibodies that was identified by OcellO in screens of colorectal cancer organoids derived by the HUB (Hubrecht Organoid Technology). This work was carried out under the suppresSTEM consortium, funded by the EU.

See the full press release here

Meet us at the AACR Annual meeting 2018 “Driving Innovative Cancer Science to Patient Care”, Chicago, USA, 14-18 April 2018

More information about the conferenceclick here

We will be presenting the following posters:

A 3D image-based quantification of T cell-mediated killing of CRC organoids in the presence of immuno-modulators.

Patient-derived 3D tumor cultures for clinical diagnostics and pre-clinical drug development.

Targeting the WNT-pathway in 3D-cultures of pancreatic cancer biopsies.

OcellO #1 of TOP 8 Innovation Picks

OcellO was selected as one of the suppliers who presented  at the Innovation Day at Medimmune in October 2016 in Gaithersburg, MD, USA  (Click here for the list of suppliers).

OcellO was chosen #1 of “TOP 8 Innovation Picks – Bringing hidden innovation to the surface” by Scientist.com. Click here for the ranking